查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1620657

药物分析测试外包市场：按服务、测试方法和最终用途分类 - 2025-2030 年全球预测

Pharmaceutical Analytical Testing Outsourcing Market by Services (Bioanalytical Testing, Method Development & Validation, Stability Testing), Testing Technique (Chromatography, Mass Spectrometry, Spectroscopy), End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年药物分析测试外包市值为92.3亿美元，预计2024年将达到100.7亿美元，复合年增长率为9.38%，到2030年将达到173亿美元。

药品分析检测外包是指委託药品的实验室检测和分析评估工作外包给外部机构。需求包括专业知识、成本效率、法规遵循以及对核心能力的关注。应用包括稳定性测试、方法验证、原材料分析和微生物测试，最终用途包括製药、生技公司和医疗设备。主要成长动力包括药物开发日益复杂、监管更加严格以及药物开发成本进一步降低。在分析测试中越来越多地采用人工智慧和机器学习等先进技术带来了潜在的机会。鼓励公司利用这些技术来提高准确性和效率，并探索策略伙伴关係以扩大服务能力和地理覆盖范围。然而，成长受到潜在资料安全挑战、依赖可能影响时间表的外部机构的风险以及全球公司之间不同的品质标准等因素的阻碍。严格遵守不断发展的国际监管标准的需要也是阻碍因素。市场发展可以透过开发个人化测试解决方案、整合巨量资料分析进行预测品质评估以及利用自动化系统来确保速度和准确性来推动。此外，与学术机构和科技新兴企业的合作可能会带来新的测试方法和可扩展的解决方案。市场的本质是动态和竞争的，既有成熟的服务供应商，也有新兴的参与者提供客製化的解决方案。随着竞争格局的演变，企业必须保持敏捷并适应不断变化的行业需求，确保强大的品管框架，并继续投资于技术进步和培训以保持竞争优势。为了领先于合规性变化，公司必须主动与监管机构合作，并将新实践无缝整合到业务工作流程中。

主要市场统计
基准年[2023] 92.3亿美元
预测年份 [2024] 100.7亿美元
预测年份 [2030] 173亿美元
复合年增长率（%） 9.38%

市场动态：快速发展的药物分析测试外包市场的关键市场洞察

药品分析测试外包市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 增加药物发现与开发的研发
    • 药物配方的复杂性日益增加以及符合严格监管标准的需要
    • 人们越来越偏好将药物分析测试外包作为成本优化策略
  • 市场限制因素
    • 维护分析设备和最先进设备的成本高昂
  • 市场机会
    • 药物检测程序的新技术进展
    • 加大医药产业投资力度
  • 市场挑战
    • 智慧财产权问题

波特五力战略工具引领药物分析测试外包市场

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药物分析测试外包市场的外部影响

外部宏观环境因素在塑造药物分析测试外包市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解药物分析测试外包市场的竞争状况

药物分析测试外包市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 药物分析测试外包市场定位矩阵供应商绩效评估

FPNV 定位矩阵是评估药物分析测试外包市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製药物分析测试外包市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对药物分析测试外包市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告提供了涵盖关键重点领域的市场全面分析：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加药物发现和开发的研究和开发
      • 药物处方的复杂性以及需要遵守严格的监管标准
      • 药物分析测试外包作为一种成本优化策略越来越受欢迎
    • 抑制因素
      • 分析设备和最先进设备的维护高成本
    • 机会
      • 药物检测程序的新技术进展
      • 加大医药产业投资力度
    • 任务
      • 智慧财产权问题
  • 市场区隔分析
    • 服务：对生物分析测试服务的需求，以确定药物的功效和安全性
    • 测试技术：层析法的主要优点在于其能够有效率地分离和定量样品中的分析物
    • 最终用途：契约製造组织对各种高度复杂的测试服务的需求不断增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药物分析测试外包市场：依服务分类

  • 生物分析测试
    • 临床
    • 非临床
  • 方法开发和检验
    • 可萃取和可浸出
    • 杂质法
    • 技术咨询
  • 稳定性测试
    • 加速稳定性测试
    • 药物成分
    • 光稳定性测试
    • 稳定性指标检验

第七章依测试方法分類的药物分析测试外包市场

  • 层析法
  • 质谱分析
  • 光谱学

第八章药物分析测试外包市场：依最终用途

  • 生物製药和药品
  • 契约製造组织

第九章 北美、南美药品分析测试外包市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太药品分析测试外包市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲药品分析测试外包市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Sterling Acuris 透过新收购扩展到製药和分析测试领域
    • Eurofins 透过与日本Astellas Pharma 签订外包协议扩大生物製药产品测试基地
  • 战略分析和建议

公司名单

  • Ajinomoto Bio-Pharma
  • Alcami Corporation
  • AptarGroup, Inc.
  • Ascendia Pharmaceuticals
  • BioAgilytix
  • Cambrex Corporation
  • Catalent, Inc
  • Charles River Laboratories International, Inc.
  • Element Materials Technology
  • Eurofins Scientific SE
  • ICON PLC
  • Intertek Group PLC
  • Laboratory Corporation of America Holdings
  • LGM Pharma
  • Medpace Holdings, Inc.
  • Merck KGaA
  • Pace Analytical Services, Inc.
  • SGS SA
  • Societal CDMO
  • Source BioScience
  • Syneos Health
  • Thermo Fisher Scientific Inc.
  • West Pharmaceutical Services, Inc.
  • WuXi AppTec
Product Code: MRR-A339DAEFAEE4

The Pharmaceutical Analytical Testing Outsourcing Market was valued at USD 9.23 billion in 2023, expected to reach USD 10.07 billion in 2024, and is projected to grow at a CAGR of 9.38%, to USD 17.30 billion by 2030.

Pharmaceutical Analytical Testing Outsourcing refers to contracting external organizations to conduct laboratory testing and analytical assessments of pharmaceutical products. It is necessitated by a need for specialized expertise, cost efficiency, regulatory compliance, and the ability to focus on core competencies. Applications include stability testing, method validation, raw material analysis, and microbiological testing, while end-use avenues cover pharmaceuticals, biotechnology firms, and medical devices. Key growth drivers include the rising complexity of drug development, stringent regulatory mandates, and the push for cost reduction in pharmaceutical development. The increasing adoption of advanced technologies like AI and machine learning for analytical testing presents potential opportunities; companies are recommended to leverage these technologies to improve accuracy and efficiency and explore strategic partnerships to expand service capabilities and geographical reach. However, growth is challenged by factors such as potential breaches in data security, dependency risks on external agencies that could affect timelines, and variability in quality standards across global players. The need for rigorous compliance with evolving international regulatory standards also poses a limitation. Market innovation can be driven by developing personalised testing solutions, integrating big data analytics for predictive quality assessments, and leveraging automated systems to ensure speed and precision. Moreover, collaboration with academic institutions and tech startups might yield new testing methodologies and scalable solutions. The nature of the market is dynamic and competitive, with a mix of established service providers and emerging players offering tailored solutions. As the landscape evolves, businesses must remain agile and responsive to changing industry needs, ensuring robust quality control frameworks while continuously investing in technological advancements and training to maintain a competitive advantage. Companies should proactively engage with regulatory bodies to stay ahead of compliance changes, ensuring seamless integration of new practices into their operational workflows.

KEY MARKET STATISTICS
Base Year [2023] USD 9.23 billion
Estimated Year [2024] USD 10.07 billion
Forecast Year [2030] USD 17.30 billion
CAGR (%) 9.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Analytical Testing Outsourcing Market

The Pharmaceutical Analytical Testing Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing research and development in drug discovery and development
    • Complexity of drug formulations and need for compliance with stringent regulatory standards
    • Growing preferences for pharmaceutical analytical testing outsourcing as a cost optimization strategy
  • Market Restraints
    • High cost of analytical instruments and maintaining state-of-the-art facilities
  • Market Opportunities
    • Emerging technological advancements in drug testing procedures
    • Increasing investments in the pharmaceutical industry
  • Market Challenges
    • Concerns associated with intellectual property rights

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Analytical Testing Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Analytical Testing Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Analytical Testing Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Analytical Testing Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Analytical Testing Outsourcing Market

A detailed market share analysis in the Pharmaceutical Analytical Testing Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Analytical Testing Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Analytical Testing Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Analytical Testing Outsourcing Market

A strategic analysis of the Pharmaceutical Analytical Testing Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Analytical Testing Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Bio-Pharma, Alcami Corporation, AptarGroup, Inc., Ascendia Pharmaceuticals, BioAgilytix, Cambrex Corporation, Catalent, Inc, Charles River Laboratories International, Inc., Element Materials Technology, Eurofins Scientific SE, ICON PLC, Intertek Group PLC, Laboratory Corporation of America Holdings, LGM Pharma, Medpace Holdings, Inc., Merck KGaA, Pace Analytical Services, Inc., SGS SA, Societal CDMO, Source BioScience, Syneos Health, Thermo Fisher Scientific Inc., West Pharmaceutical Services, Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Analytical Testing Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Bioanalytical Testing, Method Development & Validation, and Stability Testing. The Bioanalytical Testing is further studied across Clinical and Non-Clinical. The Method Development & Validation is further studied across Extractable & Leachable, Impurity Method, and Technical Consulting. The Stability Testing is further studied across Accelerated Stability Testing, Drug Substance, Photostability Testing, and Stability Indicating Method Validation.
  • Based on Testing Technique, market is studied across Chromatography, Mass Spectrometry, and Spectroscopy.
  • Based on End-use, market is studied across Biopharmaceuticals & Pharmaceuticals and Contract Manufacturing Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing research and development in drug discovery and development
      • 5.1.1.2. Complexity of drug formulations and need for compliance with stringent regulatory standards
      • 5.1.1.3. Growing preferences for pharmaceutical analytical testing outsourcing as a cost optimization strategy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of analytical instruments and maintaining state-of-the-art facilities
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technological advancements in drug testing procedures
      • 5.1.3.2. Increasing investments in the pharmaceutical industry
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with intellectual property rights
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Demand for bioanalytical testing services to determine efficacy and safety of pharmaceutical products
    • 5.2.2. Testing Technique: Significant benefits of chromatography owing to its efficiency in separating and quantifying analytes in samples
    • 5.2.3. End-use: Growing need for a broad range of high-complexity testing services from contract manufacturing organizations
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Analytical Testing Outsourcing Market, by Services

  • 6.1. Introduction
  • 6.2. Bioanalytical Testing
    • 6.2.1. Clinical
    • 6.2.2. Non-Clinical
  • 6.3. Method Development & Validation
    • 6.3.1. Extractable & Leachable
    • 6.3.2. Impurity Method
    • 6.3.3. Technical Consulting
  • 6.4. Stability Testing
    • 6.4.1. Accelerated Stability Testing
    • 6.4.2. Drug Substance
    • 6.4.3. Photostability Testing
    • 6.4.4. Stability Indicating Method Validation

7. Pharmaceutical Analytical Testing Outsourcing Market, by Testing Technique

  • 7.1. Introduction
  • 7.2. Chromatography
  • 7.3. Mass Spectrometry
  • 7.4. Spectroscopy

8. Pharmaceutical Analytical Testing Outsourcing Market, by End-use

  • 8.1. Introduction
  • 8.2. Biopharmaceuticals & Pharmaceuticals
  • 8.3. Contract Manufacturing Organizations

9. Americas Pharmaceutical Analytical Testing Outsourcing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Sterling Accuris expands into pharmaceutical and analytical testing through new acquisition
    • 12.3.2. Eurofins expands its biopharmaceutical products testing footprint with an outsourcing agreement with Astellas in Japan
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ajinomoto Bio-Pharma
  • 2. Alcami Corporation
  • 3. AptarGroup, Inc.
  • 4. Ascendia Pharmaceuticals
  • 5. BioAgilytix
  • 6. Cambrex Corporation
  • 7. Catalent, Inc
  • 8. Charles River Laboratories International, Inc.
  • 9. Element Materials Technology
  • 10. Eurofins Scientific SE
  • 11. ICON PLC
  • 12. Intertek Group PLC
  • 13. Laboratory Corporation of America Holdings
  • 14. LGM Pharma
  • 15. Medpace Holdings, Inc.
  • 16. Merck KGaA
  • 17. Pace Analytical Services, Inc.
  • 18. SGS SA
  • 19. Societal CDMO
  • 20. Source BioScience
  • 21. Syneos Health
  • 22. Thermo Fisher Scientific Inc.
  • 23. West Pharmaceutical Services, Inc.
  • 24. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)

TABLE